Anavex Life Sciences
Anavex Life Sciences Logo
About Anavex Life Sciences
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines and small molecule therapeutics for central nervous system (CNS) diseases. Its lead candidate, ANAVEX 2-73, targets Alzheimer's disease, Parkinson's disease, and rare neurological disorders such as Rett syndrome. The company also develops other drug candidates for conditions including schizophrenia, frontotemporal dementia, depression, stroke, neuropathic pain, and certain cancers. Anavex leverages its proprietary SIGMACEPTOR platform to address severe and rare CNS diseases with significant unmet medical needs. Headquartered in New York, Anavex serves clients worldwide.
Address
630 5th Avenue, 20th Floor
New York, 10111
United States
Year founded
2007
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
